Pierre Fabre

Pierre Fabre is a French multinational corporation operating in the pharmaceutical and cosmetics sectors. The company's core business encompasses the research, development, manufacturing, and distribution of both pharmaceutical products and cosmetic and dermo-cosmetic goods. Its product portfolio includes active pharmaceutical ingredients, finished dosage forms, and a wide range of skincare, hygiene, and beauty products. The organization serves a global customer base, with its international network distributing its brands and products across numerous markets worldwide. Its operations span the entire value chain from ingredient production to final consumer goods, positioning it as a significant integrated player in its fields.

The company's scale is evident in its extensive international manufacturing and distribution network, which experienced widespread operational disruption during the March 2021 cyber incidents. A distinguishing attribute of Pierre Fabre is its critical role in producing essential pharmaceutical and cosmetic ingredients, a function deemed so vital that one dedicated manufacturing facility remained operational even as others were halted as a precaution during the attack. This highlights a specialized competency in foundational ingredient synthesis for both its own branded products and potentially external clients. The firm's operational footprint is substantial, with the incident's containment requiring a day-long isolation of systems and resulting in a temporary shutdown of most production facilities globally, including those manufacturing hygiene products developed in response to the pandemic. This event underscored its significant manufacturing capacity and the interconnected nature of its international supply chain. The organization is recognized as a major entity within the French and global health and beauty industries, with its activities touching both prescription pharmaceuticals and over-the-counter consumer cosmetics.